Presence of a High Amount of Stroma and Downregulation of SMAD4 Predict for Worse Survival for Stage I–II Colon Cancer Patients

Background: For stage I–II colon cancer a significant number (5–25%) of patients has recurrent disease within 5 years. There is need to identify these high-risk patients as they might benefit from additional treatment. Stroma-tissue surrounding the cancer cells plays an important role in the tumor b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Oncol
Autors principals: Mesker, Wilma E., Liefers, Gerrit-Jan, Junggeburt, Jan M. C., van Pelt, Gabi W., Alberici, Paola, Kuppen, Peter J. K., Miranda, Noel F., van Leeuwen, Karin A. M., Morreau, Hans, Szuhai, Karoly, Tollenaar, Rob A. E. M., Tanke, Hans J.
Format: Artigo
Idioma:Inglês
Publicat: IOS Press 2009
Matèries:
Other
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4618830/
https://ncbi.nlm.nih.gov/pubmed/19478385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/CLO-2009-0478
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars